These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9057080)

  • 1. The pharmacologic profile of 606A, a novel angiotensin II receptor antagonist.
    Hashimoto Y; Harada Y; Narita H; Naito K; Murata S
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):284-90. PubMed ID: 9057080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
    Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS
    J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic profile of TA-606, a novel angiotensin II-receptor antagonist in the rat.
    Hashimoto Y; Ohashi R; Kurosawa Y; Minami K; Kaji H; Hayashida K; Narita H; Murata S
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):568-75. PubMed ID: 9554806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
    Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
    Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
    Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
    Wong PC; Quan ML; Saye JM; Bernard R; Crain EJ; McCall DE; Watson CA; Zaspel AM; Smith RD; Wexler RR
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):354-62. PubMed ID: 8583775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and binding studies of insurmountable antagonism of 606A, a novel AT1-receptor antagonist in rabbit tissues.
    Kurosawa Y; Minami K; Hashimoto Y; Narita H
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):132-8. PubMed ID: 10413079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension.
    Hashimoto Y; Ohashi R; Minami K; Narita H
    Jpn J Pharmacol; 1999 Sep; 81(1):63-72. PubMed ID: 10580372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist.
    Tamura K; Okuhira M; Amano H; Inokuma K; Hirata T; Mikoshiba I; Hashimoto K
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):607-15. PubMed ID: 9388043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL; Zhao X; Sun X; Hedner T
    J Pharm Pharmacol; 1996 Aug; 48(8):829-33. PubMed ID: 8887734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat.
    Cox SL; Story DF; Ziogas J
    Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
    Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
    Nagura J; Yasuda S; Fujishima K; Yamamoto M; Hui C; Kawano K; Katano K; Ogino H; Hachisu M; Konno F
    Eur J Pharmacol; 1995 Feb; 274(1-3):201-11. PubMed ID: 7768273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist.
    Mizuno M; Sada T; Ikeda M; Fukuda N; Miyamoto M; Yanagisawa H; Koike H
    Eur J Pharmacol; 1995 Oct; 285(2):181-8. PubMed ID: 8566137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
    Li P; Ferrario CM; Brosnihan KB
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):198-205. PubMed ID: 9700980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.